Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Income from Non-Controlling Interests (2017 - 2023)

ProQR Therapeutics' Income from Non-Controlling Interests history spans 4 years, with the latest figure at $315691.2 for Q3 2023.

  • On a quarterly basis, Income from Non-Controlling Interests rose 2136.43% to $315691.2 in Q3 2023 year-over-year; TTM through Dec 2023 was $416834.7, a 78.42% increase, with the full-year FY2023 number at $413160.9, up 84.07% from a year prior.
  • Income from Non-Controlling Interests hit $315691.2 in Q3 2023 for ProQR Therapeutics, up from $17422.8 in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for PRQR hit a ceiling of $315691.2 in Q3 2023 and a floor of -$649798.0 in Q4 2020.
  • Historically, Income from Non-Controlling Interests has averaged -$5726.2 across 4 years, with a median of -$5745.3 in 2022.
  • Biggest five-year swings in Income from Non-Controlling Interests: soared 2846.79% in 2022 and later crashed 92.48% in 2023.
  • Tracing PRQR's Income from Non-Controlling Interests over 4 years: stood at -$649798.0 in 2020, then soared by 96.66% to -$21735.4 in 2021, then surged by 85.92% to -$3060.7 in 2022, then surged by 10414.21% to $315691.2 in 2023.
  • Business Quant data shows Income from Non-Controlling Interests for PRQR at $315691.2 in Q3 2023, $17422.8 in Q2 2023, and $83720.7 in Q1 2023.